Literature DB >> 21428693

Nose-to-brain transport of melatonin from polymer gel suspensions: a microdialysis study in rats.

R Jayachandra Babu1, Pankaj Patrick Dayal, Kasturi Pawar, Mandip Singh.   

Abstract

PURPOSE: Exogenous melatonin (MT) has significant neuroprotective roles in Alzheimer's and Parkinson's diseases. This study investigates the delivery MT to brain via nasal route as a polymeric gel suspension using central brain microdialysis in anesthetized rats.
METHODS: Micronized MT suspensions using polymers [carbopol, carboxymethyl cellulose (CMC)] and polyethylene glycol 400 (PEG400) were prepared and characterized for nasal administration. In vitro permeation of the formulations was measured across a three-dimensional tissue culture model EpiAirway(™). The central brain delivery into olfactory bulb of nasally administered MT gel suspensions was studied using brain microdialysis in male Wistar rats. The MT content of microdialysis samples was analyzed by high performance liquid chromatography (HPLC) using electrochemical detection. The nose-to-brain delivery of MT formulations was compared with intravenously administered MT solution.
RESULTS: MT suspensions in carbopol and CMC vehicles have shown significantly higher permeability across Epiairway(™) as compared to control, PEG400 (P < 0.05). The brain (olfactory bulb) levels of MT after intranasal administration were 9.22, 6.77 and 4.04-fold higher for carbopol, CMC and PEG400, respectively, than that of intravenous MT in rats. In conclusion, microdialysis studies demonstrated increased brain levels of MT via nasal administration in rats.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21428693      PMCID: PMC3334865          DOI: 10.3109/1061186X.2011.558090

Source DB:  PubMed          Journal:  J Drug Target        ISSN: 1026-7158            Impact factor:   5.121


  55 in total

1.  Evaluation of different parameters that affect droplet-size distribution from nasal sprays using the Malvern Spraytec.

Authors:  Pankaj Dayal; Madhu Sudhan Shaik; Mandip Singh
Journal:  J Pharm Sci       Date:  2004-07       Impact factor: 3.534

2.  Intranasal insulin improves memory in humans.

Authors:  Christian Benedict; Manfred Hallschmid; Astrid Hatke; Bernd Schultes; Horst L Fehm; Jan Born; Werner Kern
Journal:  Psychoneuroendocrinology       Date:  2004-11       Impact factor: 4.905

3.  Enhancement of nose-brain delivery of therapeutic agents for treating neurodegenerative diseases using peppermint oil.

Authors:  S R Kiran Vaka; S Narasimha Murthy
Journal:  Pharmazie       Date:  2010-09       Impact factor: 1.267

4.  Effect of viscosity on particle size, deposition, and clearance of nasal delivery systems containing desmopressin.

Authors:  A S Harris; E Svensson; Z G Wagner; S Lethagen; I M Nilsson
Journal:  J Pharm Sci       Date:  1988-05       Impact factor: 3.534

Review 5.  Morphine metabolites.

Authors:  L L Christrup
Journal:  Acta Anaesthesiol Scand       Date:  1997-01       Impact factor: 2.105

6.  Inhibition of Alzheimer beta-fibrillogenesis by melatonin.

Authors:  M Pappolla; P Bozner; C Soto; H Shao; N K Robakis; M Zagorski; B Frangione; J Ghiso
Journal:  J Biol Chem       Date:  1998-03-27       Impact factor: 5.157

7.  Brain uptake of dihydroergotamine after intravenous and nasal administration in the rat.

Authors:  Y Wang; R Aun; F L Tse
Journal:  Biopharm Drug Dispos       Date:  1998-12       Impact factor: 1.627

8.  Different types of melatonin circadian secretory rhythms in some blind subjects.

Authors:  A J Lewy; D A Newsome
Journal:  J Clin Endocrinol Metab       Date:  1983-06       Impact factor: 5.958

Review 9.  The antiapoptotic activity of melatonin in neurodegenerative diseases.

Authors:  Xin Wang
Journal:  CNS Neurosci Ther       Date:  2009-10-10       Impact factor: 5.243

Review 10.  Rheology of biopolymer solutions and gels.

Authors:  David R Picout; Simon B Ross-Murphy
Journal:  ScientificWorldJournal       Date:  2003-03-24
View more
  3 in total

1.  Nose-To-Brain Delivery of PLGA-Diazepam Nanoparticles.

Authors:  Deepak Sharma; Rakesh Kumar Sharma; Navneet Sharma; Reema Gabrani; Sanjeev K Sharma; Javed Ali; Shweta Dang
Journal:  AAPS PharmSciTech       Date:  2015-02-21       Impact factor: 3.246

2.  Formulations for Intranasal Delivery of Pharmacological Agents to Combat Brain Disease: A New Opportunity to Tackle GBM?

Authors:  Matthias van Woensel; Nathalie Wauthoz; Rémi Rosière; Karim Amighi; Véronique Mathieu; Florence Lefranc; Stefaan W van Gool; Steven de Vleeschouwer
Journal:  Cancers (Basel)       Date:  2013-08-14       Impact factor: 6.639

Review 3.  Micro- and Nanosized Carriers for Nose-to-Brain Drug Delivery in Neurodegenerative Disorders.

Authors:  Radka Boyuklieva; Bissera Pilicheva
Journal:  Biomedicines       Date:  2022-07-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.